What was the result of the ACCORD trial regarding glycemic control and combination lipid-lowering treatment?
The ACCORD trial showed that intensive glycemic control and combination lipid-lowering treatment, but not intensive BP control, was associated with a reduction in the rate of progression of retinopathy.